PDPN and cancer: Another non-cytotoxic 5-nitrobenzoate compound, 2CP, specifically inhibited the podoplanin-CLEC-2 interaction and TCIPA [233] resulting in anti-cancer metastatic activity in vivo in the experimental animal model.